BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This scope aligns to the NHS Long Term Plan (LTP) commitment that the NHS Genomic Medicine Service will sequence 500,000 whole genomes by 2023/24. As was stated in the LTP, this commitment builds on the legacy of the ground-breaking 100,000 Genomes Project, that was made possible because of the unique partnership between Genomics England and the NHS. As part of this ambition, the LTP outlined that during 2019/20, seriously ill children who are likely to have a rare genetic disorder, children with cancer, and adults suffering from certain rare conditions or specific cancers, will begin to be offered whole genome sequencing.
The scope also aligns with wider objectives, including:
⢠Achieving the ambitions and NHS England & NHS Improvement's commitments set out in the UK Strategy for Rare Diseases;
⢠Meeting the deliverables set out in the NHS England & NHS Improvement Personalised Medicine Strategy;
⢠Aligning with the NHS England & NHS Improvement Cancer Programme deliverables in respect of molecular diagnoses for cancer; and
⢠Government strategy for life sciences - life sciences sector deal.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Answer Digital Limited | 03655429 | £318,000 | - |
Government spending data: This supplier has received £26,732,786 in 382 payments (over £25k) from Manchester University NHS Foundation Trust, NHS England, Department of Health and Social Care, Ministry of Defence, Guy's and St Thomas' NHS FT and 3 more public bodies (2016-07-12 to 2026-04-20). View full payment history →